[Anti-Her2 therapy in breast cancer].
Tokyo Metropolitan Cancer and Infectious Diseases Center, Komagome Hospital.
Katsumasa
K
Kuroi
D001943:Breast Neoplasms / Q000188:drug therapy*; D005260:Female; D006801:Humans; D058990:Molecular Targeted Therapy; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000276:immunology
D018719:Erb-b2 Receptor Tyrosine Kinases; C508053:ERBB2 protein, human